Dr. Wolfgang Rehmann

Wolfgang is one of the leading experts on pharmaceutical law and medical device law in Germany. With his many years of industry knowledge and international experience, he represents small and medium-sized companies from the pharmaceutical and medical device industries, as well as global players.

In the Life Sciences team of Taylor Wessing, Wolfgang develops solutions for complex, strategic challenges facing this sector. In addition, he represents his clients' interests before authorities and in court, including in European court proceedings in Luxembourg. Wolfgang is also a lecturer at the University of Münster and at the University of Marburg.

Afficher le CV complet Masquer le CV complet

Carrière

Since 1987	Partner, Taylor Wessing
1983 – 1987	Associate, Zimmermann Hohelohe Sommer Rojahn
1982 – 1983	In-house Counsel, Fraunhofer Gesellschaft

Formation

1983	Admitted as a lawyer, Munich
1983	Doctoral degree, Dr. iur. utr., Ludwig-Maximilians-Universität of Würzburg
1982	Second state examination, Bayern

1979

First state examination, Würzburg

Voir plus Moins

Publications

AMG Kommentar Beck Verlag

MPG Kommentar co-author Beck Verlag

Arzthaftungsprozess, Luchterhand co-author

Arzneimittel und Recht, regular publications

PharmaRecht, regular publications

Medzinprodukte Journal, regular publications

Medizinproduktrecht, regular publications

Groupes & Associations

GRUR
LIDC

Langues étrangères

English

French

Expertise

Services et Groupes Brevets et innovation Règlementation des sciences de la vie Groupe franco-allemand

Secteurs Sciences de la vie et Santé Biotech Cosmétiques, alimentation et compléments alimentaires Dispositifs médicaux Produits pharmaceutiques e-santé

Experience

Hauck & Aufhäuser	A Taylor Wessing team led by Frankfurt-based partners Lars-Gerrit Lüßmann and Ulrich Reers advised Hauck & Aufhäuser Investment Banking and Polish universal bank mBank in their role as exchange trustee and settlement agent on the voluntary public takeover/exchange offer by Frankfurt-listed Vita 34 AG, Leipzig, to the shareholders of Warsaw-listed stem cell bank Polski Bank Komórek Macierzystych S.A, Warsaw (PBKM). The transaction is the first cross-border exchange offer for a Polish listed company to date.
Pharmaceutical portfolio divestments across 24 EU jurisdictions	Teva Pharmaceuticals Europe BV on its divestments of portfolios of generic pharmaceutical products (approximately 260 medicinal products) in 24 EU jurisdictions to multiple purchasers, in addition to advising Teva on the divestment of certain parts of its business. The divestments were a condition enforced by the European Commission to approve Teva's USD40.5 billion acquisition of Allergan plc’s global generics and have been run as a competitive auction process, resulting in five asset sales.
Provision of pan-European pharma and patent advice	A leading international healthcare company on provision of European-wide advice across a variety of legal areas including pharmaceutical law and patents.

Prix et distinctions

Who's Who Legal 2023	National Leader - Germany - Life Sciences 2023
Chambers and Partners 2023	Ranked with Chambers and Partners for Life Sciences (Germany)
JUVE Handbook 2022/2023	"expert in the field of medical device law, always available, reliable answers and practical solutions", "competent, fast, good network of correspondence lawyers", client
The Best Lawyers™ in Germany 2017- 2022	Leading individual: Pharmaceutical law
The Best Lawyers™ in Germany 2021, 2022	Leading individual: Biotechnology law
Who's Who Legal 2022	Global Leader - Regulatory
Who's Who Legal 2022	Thought Leaders - Germany - Life Sciences 2022
The Best Lawyers™ in Germany 2017, 2018, 2019, 2020, 2021, 2022	Leading individual: Health Law
JUVE Handbook 2020/2021	"Proven expert in pharmaceutical law, very satisfied", client
JUVE Handbook 2020/2021	Frequently recommended for pharmaceuticals and medical products
The Best Lawyers™ in Germany 2020	Lawyer of the year 2020: Health law
Chambers Europe 2020	Leading individual - Life Sciences - Germany: The "very strong" Wolfgang Rehmann advises clients on the regulatory aspects of transactions, as well as on compliance issues and clinical trial matters.
JUVE Handbook 2019/2020	"Grandseigneur of pharmaceutical law", competitor
JUVE Handbook 2019/2020	Frequently recommended: Pharmaceuticals and Medical Products
Chambers Europe 2019	Leading individual - Germany: "a highly knowledgeable and very pleasant person, who is very kind and pragmatic and has a lot of patience"
Chambers Europe 2019	Leading individual: Life Sciences - Germany
Legal 500 Germany 2020	Leading individual for health law
The Best Lawyers™ in Germany 2018	Healthcare Law “Lawyer of the Year” in Germany
JUVE Handbook 2016/2017	Frequently recommended: Life Sciences
ILO Client Choice Awards 2016	Client Choice Winner - Healthcare & Life Sciences (Germany)